https://geneonline.news/雙有效載荷抗體藥物複合體成癌症治療新趨勢-3/2026-05-04T02:14:11.000Zweekly0.8 https://geneonline.news/中國生物科技公司kailera擴大ipo規模/2026-05-04T02:14:04.000Zweekly0.8 https://geneonline.news/前顧問揭露fda內部運作：謹慎源於獨立與嚴謹/2026-05-04T02:13:59.000Zweekly0.8 https://geneonline.news/腦白質營養不良症藥物開發朝精準醫療邁進/2026-05-04T02:13:53.000Zweekly0.8 https://geneonline.news/生技產業ipo熱絡-後續募資與策略投資並行/2026-05-04T02:13:47.000Zweekly0.8 https://geneonline.news/美國會提案禁採中國臨床數據-憂慮中國影響力/2026-05-04T02:13:42.000Zweekly0.8 https://geneonline.news/基因體學先驅克雷格文特辭世-享壽八十歲/2026-05-04T02:13:36.000Zweekly0.8 https://geneonline.news/fda預算提案-兒童藥物優先審查永久化業界代表退出/2026-05-04T02:13:29.000Zweekly0.8 https://geneonline.news/grey-wolf和鉑醫藥人事異動-生技產業策略新布局/2026-05-04T02:13:25.000Zweekly0.8 https://geneonline.news/禮來天價收購kelonia押注體內car-t療法/2026-05-04T02:13:18.000Zweekly0.8 https://geneonline.news/nektar禿髮療法現曙光-後期反應引關注/2026-05-04T02:13:12.000Zweekly0.8 https://geneonline.news/生技產業動態-禮來收購car-t公司-kailera肥胖療法ipo受矚/2026-05-04T02:13:06.000Zweekly0.8 https://geneonline.news/川普迷幻藥行政命令引發監管爭議/2026-05-04T02:12:59.000Zweekly0.8 https://geneonline.news/生技醫藥併購潮湧現-ucb禮來搶攻創新療法/2026-05-04T02:12:53.000Zweekly0.8 https://geneonline.news/生技併購市場現重大變革-私募生技公司成新寵/2026-05-04T02:12:47.000Zweekly0.8 https://geneonline.news/英國生技公司開發新型cdk46抑制劑-治療類風濕性關節/2026-05-04T02:12:43.000Zweekly0.8 https://geneonline.news/多區域臨床試驗未成藥物開發常態/2026-05-04T02:12:36.000Zweekly0.8 https://geneonline.news/腦脊髓液生物標記有助區分額顳葉失智症-2/2026-05-04T02:12:31.000Zweekly0.8 https://geneonline.news/自體免疫疾病治療新趨勢：精準控制b細胞清除成關/2026-05-04T02:12:24.000Zweekly0.8 https://geneonline.news/安進主管退休-biomarin迎新董事長/2026-05-04T02:12:18.000Zweekly0.8 https://geneonline.news/aacr年會聚焦腫瘤治療數據與技術創新-3/2026-05-04T02:12:13.000Zweekly0.8 https://geneonline.news/泛ras抑制劑抗體偶聯藥物成癌症治療新希望/2026-05-04T02:12:08.000Zweekly0.8 https://geneonline.news/創投押寶神經學藥物開發-tortugas獲資金挹注/2026-05-04T02:12:01.000Zweekly0.8 https://geneonline.news/細胞療法臨床試驗領先-中國生物科技崛起成推動力/2026-05-04T02:11:57.000Zweekly0.8 https://geneonline.news/生技併購里程碑付款成趨勢-3/2026-05-04T02:11:52.000Zweekly0.8 https://geneonline.news/川普政府胜肽迷幻藥決策模式引發小型生技公司擔/2026-05-04T02:11:45.000Zweekly0.8 https://geneonline.news/禿髮藥物數據亮眼-nektar募資成功-first-tracks-bio上市/2026-05-04T02:11:42.000Zweekly0.8 https://geneonline.news/賽諾菲btk抑制劑獲歐盟藥品管理局正面評價/2026-05-04T02:11:35.000Zweekly0.8 https://geneonline.news/inventiva高層重組備戰關鍵數據發布/2026-05-04T02:11:29.000Zweekly0.8 https://geneonline.news/orka-001乾癬治療二期臨床pasi-100數據亮眼/2026-05-04T02:11:28.000Zweekly0.8 https://geneonline.news/aacr會議聚焦癌症新靶點-生物製藥交易活躍-kurma基金受關/2026-05-04T02:11:26.000Zweekly0.8 https://geneonline.news/intellia基因編輯療法後期試驗告捷-面臨市場嚴峻考驗/2026-05-04T02:11:08.000Zweekly0.8 https://geneonline.news/禮來收購ajax擴大產品組合/2026-05-04T02:11:02.000Zweekly0.8 https://geneonline.news/美國癌症研究協會揭露172個新癌症治療標靶/2026-05-04T02:10:56.000Zweekly0.8 https://geneonline.news/歐洲投資機構kurma募資逾兩億歐元加碼生技新創/2026-05-04T02:10:51.000Zweekly0.8 https://geneonline.news/aurora獲千萬美元融資-推進鹼基編輯技術治療苯丙酮尿/2026-05-04T02:10:50.000Zweekly0.8 https://geneonline.news/罕見兒科疾病優先審查憑證價格居高不下-4/2026-05-04T02:10:48.000Zweekly0.8 https://geneonline.news/teva製藥七億美元收購emalex擴大兒童神經疾病影響力/2026-05-04T02:10:46.000Zweekly0.8 https://geneonline.news/罕見疾病藥物審批政策引爭議-小型生技公司挑戰fda/2026-05-04T02:10:25.000Zweekly0.8 https://geneonline.news/降低體內car-t細胞免疫原性研究獲關注-3/2026-05-04T02:10:18.000Zweekly0.8 https://geneonline.news/生物科技產業資金湧入-coultreon獲巨額融資/2026-05-04T02:10:12.000Zweekly0.8 https://geneonline.news/syncona轉型聚焦因果生物學-基因療法成投資重點/2026-05-04T02:10:08.000Zweekly0.8 https://geneonline.news/印度陽光製藥斥資百億美元收購默克旗下organon公司/2026-05-04T02:10:03.000Zweekly0.8 https://geneonline.news/諾華藥廠蕁麻疹與瘧疾療法獲歐盟批准/2026-05-04T02:09:58.000Zweekly0.8 https://geneonline.news/阿斯特捷利康狼瘡新藥獲fda批准-患者可自行注射/2026-05-04T02:09:52.000Zweekly0.8 https://geneonline.news/biomarin完成收購amicus擴展罕見疾病藥物產品線/2026-05-04T02:09:47.000Zweekly0.8 https://geneonline.news/rocket-pharmaceuticals出售優先審查憑證挹注基因治療研發-2/2026-05-04T02:09:43.000Zweekly0.8 https://geneonline.news/arcera與復星醫藥合作推動神經科學創新/2026-05-04T02:09:38.000Zweekly0.8 https://geneonline.news/再生元公司第一季度淨利下滑/2026-05-04T02:09:33.000Zweekly0.8 https://geneonline.news/ray-therapeutics基因療法獲歐盟ema優先藥物資格-2/2026-05-04T02:09:28.000Zweekly0.8 https://geneonline.news/丹麥-leo-pharma-收購-replay-強化基因療法能力/2026-05-04T02:09:23.000Zweekly0.8 https://geneonline.news/fda批准新藥auvelity治療阿茲海默症躁動-7/2026-05-04T02:09:18.000Zweekly0.8 https://geneonline.news/glp1藥物法律政策高峰會探討市場挑戰與監管趨勢/2026-05-04T02:09:11.000Zweekly0.8 https://geneonline.news/fda收緊胜肽藥物監管藥品調劑業者面臨挑戰/2026-05-04T02:09:06.000Zweekly0.8 https://geneonline.news/美國fda更新法規重視藥品丟棄議題/2026-05-04T02:08:59.000Zweekly0.8 https://geneonline.news/fda加強監管胜肽藥物-調劑業者面臨合規挑戰-2/2026-05-04T02:08:54.000Zweekly0.8 https://geneonline.news/美國司法部新政策影響藥品食品產業-強化企業責任/2026-05-04T02:08:48.000Zweekly0.8 https://geneonline.news/fda重申臨床試驗報告重要性-籲遵守clinicaltrials規範-2/2026-05-04T02:08:43.000Zweekly0.8 https://geneonline.news/快速診斷技術崛起-監管如何兼顧速度與準確性/2026-05-04T02:08:36.000Zweekly0.8 https://geneonline.news/美國fda監管風波再起-公民請願書挑戰藥廠/2026-05-04T02:08:30.000Zweekly0.8 https://geneonline.news/美國大麻監管現況-fda批准產品重新排程/2026-05-04T02:08:23.000Zweekly0.8 https://geneonline.news/fda公開未申報藥品數量企業名單-加強藥品供應鏈監/2026-05-04T02:08:18.000Zweekly0.8 https://geneonline.news/樞紐模式轉型：適應性與共享策略成關鍵/2026-05-04T02:08:13.000Zweekly0.8 https://geneonline.news/藥品通路研究所舉辦pbm產業線上研討會/2026-05-04T02:08:08.000Zweekly0.8 https://geneonline.news/藥廠重塑共付額協助方案應對醫療成本挑戰/2026-05-04T02:08:03.000Zweekly0.8 https://geneonline.news/美國藥局營收成長-glp1藥物成主要動力/2026-05-04T02:07:57.000Zweekly0.8 https://geneonline.news/醫療福利最大化機構崛起-藥廠面臨市場新挑戰/2026-05-04T02:07:51.000Zweekly0.8 https://geneonline.news/美國藥局與藥品福利管理機構2026經濟報告發布/2026-05-04T02:07:45.000Zweekly0.8 https://geneonline.news/藥品通路領導論壇圓滿落幕聚焦產業洞見/2026-05-04T02:07:39.000Zweekly0.8 https://geneonline.news/罕見疾病照護模式需重新定義-專業藥局成患者希望/2026-05-04T02:07:33.000Zweekly0.8 https://geneonline.news/美國pbm市場寡佔，三大巨頭面臨轉型挑戰/2026-05-04T02:07:27.000Zweekly0.8 https://geneonline.news/藥品通路春季新訊：信諾整合、默克藥價、沃爾格/2026-05-04T02:07:20.000Zweekly0.8 https://geneonline.news/應對醫療挑戰-covermymeds-舉辦創新圓桌會議/2026-05-04T02:07:12.000Zweekly0.8 https://geneonline.news/美國三大pbm處方集轉向自有品牌生物相似藥/2026-05-04T02:07:05.000Zweekly0.8 https://geneonline.news/藥品通路產業重大議題剖析與未來展望/2026-05-04T02:06:58.000Zweekly0.8 https://geneonline.news/美國藥品降價潮衝擊藥局與340b計畫/2026-05-04T02:06:51.000Zweekly0.8 https://geneonline.news/美國聯邦貿易委員會重塑藥品通路express-scripts和解協議引/2026-05-04T02:06:45.000Zweekly0.8 https://geneonline.news/美國藥品通路淨價革命來臨-4/2026-05-04T02:06:38.000Zweekly0.8 https://geneonline.news/生命科學定價合約美國峰會聚焦醫療保健挑戰/2026-05-04T02:06:32.000Zweekly0.8 https://geneonline.news/美國藥品通路垂直整合加劇-市場壟斷與患者權益引/2026-05-04T02:06:25.000Zweekly0.8 https://geneonline.news/藥品樞紐轉移風險與應對策略/2026-05-04T02:06:19.000Zweekly0.8 https://geneonline.news/醫療機構導入全通路客戶關係管理系統優化特殊療/2026-05-04T02:06:13.000Zweekly0.8 https://geneonline.news/特殊藥房市場集中度高-pbm附屬藥房佔據主導地位-2/2026-05-04T02:06:08.000Zweekly0.8 https://geneonline.news/藥廠轉型直達消費者模式-整合定價需求配送擴大-2/2026-05-04T02:05:56.000Zweekly0.8 https://geneonline.news/藥品通路聚焦pbm專業藥房患者體驗與非營利醫院財/2026-05-04T02:05:50.000Zweekly0.8 https://geneonline.news/藥廠營收管理新挑戰-理賠層面毛利淨利風險浮現/2026-05-04T02:05:45.000Zweekly0.8 https://geneonline.news/歐盟新藥聯合評估系統面臨挑戰/2026-05-04T02:05:39.000Zweekly0.8 https://geneonline.news/teva製藥九億美元收購emalex強化後期產品線/2026-05-04T02:05:33.000Zweekly0.8 https://geneonline.news/奇亞esi斥資19億美元收購kalvista擴展罕見疾病產品線/2026-05-04T02:05:28.000Zweekly0.8 https://geneonline.news/抗凝血藥專利到期-藥廠面臨140億美元營收危機/2026-05-04T02:05:23.000Zweekly0.8 https://geneonline.news/leo-pharma收購replay擴大基因療法布局-2/2026-05-04T02:05:17.000Zweekly0.8 https://geneonline.news/百時美施貴寶重點藥物臨床試驗結果將揭曉/2026-05-04T02:05:12.000Zweekly0.8 https://geneonline.news/禮來減重藥品需求強勁，上調2026年營收預期/2026-05-04T02:05:06.000Zweekly0.8 https://geneonline.news/fda批准新藥auvelity治療阿茲海默症躁動-6/2026-05-04T02:05:02.000Zweekly0.8 https://geneonline.news/沙烏地阿拉伯崛起成中東臨床試驗中心-2/2026-05-04T02:04:57.000Zweekly0.8 https://geneonline.news/技術碎片化推升臨床試驗成本-整合數據管理成解方/2026-05-04T02:04:52.000Zweekly0.8 https://geneonline.news/安邁企業諮詢任命nitin-lath為印度企業財務董事總經理/2026-05-04T02:04:47.000Zweekly0.8 https://geneonline.news/印度藥廠推出新注射劑對抗多重抗藥性感染-2/2026-05-04T02:04:43.000Zweekly0.8 https://geneonline.news/vision-360研討會聚焦眼科研究轉譯與創新技術/2026-05-04T02:04:37.000Zweekly0.8 https://geneonline.news/印度製藥展覽聚焦產業未來發展/2026-05-04T02:04:31.000Zweekly0.8